Project Overview

0
Rate this post

Hansa Medical is a biopharmaceutical business establishing novel immunomodulatory enzymes for transplant and acute autoimmune diseases. The lead projet imlifidase (IdeS) is a proprietary antibody-degrading enzyme presently in late-stage medical development for kidney transplant patients with substantial potential for more growth in other strong body organ transplants and also a vast array of intense autoimmune signs.

The business likewise has a strong pipe of preclinical possessions that may offer a 2nd wave of prospective medicines. Under the task name NiceR, novel immunoglobulin cleaving enzymes are developed for repeat dosing translating the Hansa Medical innovation right into slipping back autoimmune diseases and also potentially oncology.

LÄMNA ETT SVAR

Vänligen ange din kommentar!
Vänligen ange ditt namn här